Log in or Sign up for Free to view tailored content for your specialty!
Practice Management News
FDA takes new steps to curb opioid crisis
The FDA announced several new strategies today to better inform medical professionals and patients about the risks associated with opioid use.
Team-based health care improves patient outcomes, physician well-being
Implementing optimal team-based health care is associated with improvements in patient outcomes, the efficiency of care and the well-being and satisfaction of clinicians, according to a discussion paper published in the National Academy of Medicine Perspectives.
Log in or Sign up for Free to view tailored content for your specialty!
Burnout frequency varies by specialty, but exact prevalence unclear
Symptoms of burnout and career choice regret were common among U.S. resident physicians, but differed substantially by clinical specialty, according to findings recently published in JAMA.
Drug prices rise twice as fast during shortages
During a shortage, drug prices increase two times as quickly as they would have in the absence of a shortage, according to findings published in Annals of Internal Medicine.
Patients with multiple prescribers more likely to seek ‘high-risk’ prescriptions
Lower continuity of prescribing, as measured by the continuity of care index, was strongly linked to the likelihood for filling high-risk opioid prescriptions or being hospitalized for an opioid-related cause, among patients with long-term opioid use, according to findings recently published in Annals of Family Medicine.
Documentation for justifying opioid prescriptions often lacking
A medical indication is not documented for many outpatient opioid prescriptions, according to findings published in Annals of Internal Medicine.
Chronic pain may contribute to suicide deaths
Chronic pain was prevalent in nearly 9% of individuals who died by suicide, according to research published in Annals of Internal Medicine.
FDA approves Cassipa for medication-assisted treatment for opioid dependence
Today, the FDA announced the approval of Cassipa, developed by Teva Pharmaceuticals for the maintenance treatment of opioid dependence.
Past rulings may provide insight on how Supreme Court nominee Kavanaugh may impact health care
The Senate Judiciary Committee began hearings this week for Supreme Court nominee Brett Kavanaugh. The former Supreme Court law clerk and presidential staff member received the American Bar Association committee’s highest rating of “well-qualified,” which the association said is not based on philosophy or political ideology.
Long-term opioid therapy management does not usually diminish doctor-patient trust
Patients receiving chronic opioid therapy typically reported favorable perceptions of doctor-patient trust on the subject of long-term opioid therapy management, according to findings recently published in the Journal of the American Board of Family Medicine.
-
Headline News
Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?
September 27, 20245 min read -
Headline News
Prenatal cannabis use in California nearly doubled amid legalization from 2012 to 2022
September 26, 20242 min read -
Headline News
'Encouraging': Antiviral ziresovir shows promise against RSV in infants
September 26, 20242 min read
-
Headline News
Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?
September 27, 20245 min read -
Headline News
Prenatal cannabis use in California nearly doubled amid legalization from 2012 to 2022
September 26, 20242 min read -
Headline News
'Encouraging': Antiviral ziresovir shows promise against RSV in infants
September 26, 20242 min read